Viva Ventures Biotech Fund Completed $61M Initial Closing for its USD Biotech Fund II

April 8, 2021

【Portfolio News】Dogma Therapeutics Announces Global Acquisition of Oral PCSK9 Inhibitor Program by AstraZeneca

September 17, 2020

January 30, 2020

December 23, 2019